FDA Inspection
Xinxiang Tuoxin Pharmaceutical Co. LtdXinxiang Tuoxin Pharmaceutical Co. Ltd – FDA Inspection, Jun 6, 2019
Record Details
This FDA Inspection record concerns Xinxiang Tuoxin Pharmaceutical Co. Ltd, with an inspection on June 6, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0ae3dd15-5ffc-4835-9b28-f8e6c64d85a0
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1095514
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Xinxiang Tuoxin Pharmaceutical Co. Ltd
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 22, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 18, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 3, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Xinxiang Tuoxin Pharmaceutical Co. Ltd
- FDA Inspection 1155762 - 2021-10-22
- FDA Inspection 946143 - 2015-09-18
- FDA Inspection 754959 - 2011-11-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.